These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 22537764

  • 21. Serum levels of tumor necrosis factor and soluble interleukin 2 receptor as markers of disease activity and prognosis in childhood leukemia and lymphoma.
    Kalmanti M, Karamolengou K, Dimitriou H, Tosca A, Vlachonikolis I, Peraki M, Georgoulias V, Kalmantis T.
    Int J Hematol; 1993 Apr; 57(2):147-52. PubMed ID: 8494993
    [Abstract] [Full Text] [Related]

  • 22. Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.
    Guc D, Canpinar H, Kucukaksu C, Kansu E.
    Eur J Haematol; 2000 Jan; 64(1):3-9. PubMed ID: 10680700
    [Abstract] [Full Text] [Related]

  • 23. The receptor tyrosine kinase p185HER2 is expressed on a subset of B-lymphoid blasts from patients with acute lymphoblastic leukemia and chronic myelogenous leukemia.
    Bühring HJ, Sures I, Jallal B, Weiss FU, Busch FW, Ludwig WD, Handgretinger R, Waller HD, Ullrich A.
    Blood; 1995 Sep 01; 86(5):1916-23. PubMed ID: 7544646
    [Abstract] [Full Text] [Related]

  • 24. P-glycoprotein and drug resistance in acute leukemias and in the blastic crisis of chronic myeloid leukemia.
    Carulli G, Petrini M, Marini A, Vaglini F, Caracciolo F, Grassi B.
    Haematologica; 1990 Sep 01; 75(6):516-21. PubMed ID: 1982999
    [Abstract] [Full Text] [Related]

  • 25. Relationship between levels of serum gastric inhibitory polypeptide (GIP), soluble interleukin-2 receptor (sIL-2R), and soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and disease condition and prognosis of patients with severe acute pancreatitis.
    Zeng L, Xi F, Yang Y, Guo L, Hu H, Yang Q, Ma Q.
    Ann Palliat Med; 2021 Jun 01; 10(6):6786-6792. PubMed ID: 34154356
    [Abstract] [Full Text] [Related]

  • 26. Chronic myeloid leukemia blast crisis presented with AML of t(9;22) and t(3;14) mimicking acute lymphocytic leukemia.
    Liu K, Hu J, Wang X, Li L.
    J Clin Lab Anal; 2019 Oct 01; 33(8):e22961. PubMed ID: 31218758
    [Abstract] [Full Text] [Related]

  • 27. Granulocyte colony-stimulating factor receptors on human acute leukemia: biphenotypic leukemic cells possess granulocyte colony-stimulating factor receptors.
    Shimoda K, Okamura S, Harada N, Ikematsu W, Kondo S, Kawasaki C, Tanaka T, Etou T, Akashi K, Okamura T.
    Cancer Res; 1992 Jun 01; 52(11):3052-5. PubMed ID: 1534271
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Circulating immune complexes in acute leukemia.
    Cermák J, Feyereislová A, Horejsí J.
    Neoplasma; 1989 Jun 01; 36(1):21-7. PubMed ID: 2704422
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Flow cytometric analysis of expression of interleukin-2 receptor beta chain (p70-75) on various leukemic cells.
    Hoshino S, Oshimi K, Tsudo M, Miyasaka M, Teramura M, Masuda M, Motoji T, Mizoguchi H.
    Blood; 1990 Aug 15; 76(4):767-74. PubMed ID: 2383656
    [Abstract] [Full Text] [Related]

  • 33. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z, Takahashi M, Aoki S, Toba K, Liu A, Osman Y, Takahashi H, Tsukada N, Suzuki N, Nikkuni K, Furukawa T, Koike T, Aizawa Y.
    J Exp Clin Cancer Res; 1998 Sep 15; 17(3):251-8. PubMed ID: 9894758
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Blastic phase of chronic myelogenous leukemia.
    Karbasian Esfahani M, Morris EL, Dutcher JP, Wiernik PH.
    Curr Treat Options Oncol; 2006 May 15; 7(3):189-99. PubMed ID: 16615875
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Immunological classification of chronic myeloid leukemia distinguishes chronic phase, imminent blastic transformation, and acute lymphoblastic leukemia.
    Schmetzer HM, Gerhartz HH.
    Exp Hematol; 1997 Jun 15; 25(6):502-8. PubMed ID: 9197328
    [Abstract] [Full Text] [Related]

  • 38. [The role of serum soluble interleukin 2 receptor (sIL-2R) levels in patients with renal cell carcinoma].
    Akiyama K, Tsuji M, Kurokawa Y, Yokota K, Kojima K, Naruo S, Kanayana HO, Kagawa S.
    Nihon Hinyokika Gakkai Zasshi; 1997 Apr 15; 88(4):473-8. PubMed ID: 9155114
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.